Skip to main content

Table 4 Subsequent regimens in case a stavudine containing regimen was substituted with another first line combination

From: cART prescription trends in a prospective HIV cohort in rural Tanzania from 2007 to 2011

  2007 2008 2009 2010 2011
  (n = 18) (n = 46) (n = 66) (n = 69) (n = 43)
AZT/3TC/NVP 2 (11.1%) 22 (47.8) 23 (34.8%) 32 (46.4%) 18 (41.9%)
AZT/3TC/EFV 16 (88.9%) 24 (52.2%) 30 (45.5%) 6 (8.7%) 3 (7%)
TDF/FTC/EFV 0 0 13 (19.7%) 31 (44.9%) 22 (51.1%)
  1. Data is presented in counts (column percentage). In case of >1 regimen per year per patient, multiple counts per patients are included in one year. Total number (n) represents sum of patients per year, not sum of regimen counts listed.